|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/135 | |||
| A61K 47/02 |
| (11) | Number of the document | 1731143 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06011513.6 |
| Date of filing the European patent application | 2006-06-02 | |
| (97) | Date of publication of the European application | 2006-12-13 |
| (45) | Date of publication and mention of the grant of the patent | 2008-11-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 2005165051 | 2005-06-06 | JP |
| (72) |
Inosaka, Keigo, JP
Muraoka, Takateru, JP
Iwao, Yoshihiro, JP
Takada, Akio, JP
Tsuda, Toshinobu, JP
Sekiya, Junichi, JP
|
| (73) |
NITTO DENKO CORPORATION,
1-2, Shimohozumi 1-chome Ibaraki-shi, Osaka,
JP
Fujimoto Co., Ltd., 3-40, Nishiotsuka 1-chome, Matsubara-shi, Osaka 580-0011, JP |
| (54) | Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure |
| Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure |